Navegar

Colección

Datos Estadísticas

Lista de

metastasis inhibition
6
"Angiotensin-(1-7) counteracts the transforming effects triggered by angiotensin II in breast cancer cells" (2017) Cambados, N.;Walther, T.;Nahmod, K. (...)Schere-Levy, C. Oncotarget. 8(51):88475-88487
"Synergistic Antiproliferative Effects of a New Cucurbitacin B Derivative and Chemotherapy Drugs on Lung Cancer Cell Line A549" (2015) Marostica, L.L.;Silva, I.T.;Kratz, J.M. (...)Simões, C.M.O. Chemical Research in Toxicology. 28(10):1949-1960
"Preclinical development of novel Rac1-GEF signaling inhibitors using a rational design approach in highly aggressive breast cancer cell lines" (2014) Cardama, G.A.;Comin, M.J.;Hornos, L. (...)Menna, P.L. Anti-Cancer Agents in Medicinal Chemistry. 14(6):840-851
"Targeting galectin-1 overcomes breast cancer-associated immunosuppression and prevents metastatic disease" (2013) Dalotto-Moreno, T.;Croci, D.O.;Cerliani, J.P. (...)Salatino, M. Cancer Research. 73(3):1107-1117
"Neuroblastoma triggers an immunoevasive program involving galectin-1-dependent modulation of T cell and dendritic cell compartments" (2012) Soldati, R.;Berger, E.;Zenclussen, A.C. (...)Fest, S. International Journal of Cancer. 131(5):1131-1141
"Nerve growth factor and retinoic acid inhibit proliferation and invasion in thyroid tumor cells" (2000) Páez Pereda, M.;Missale, C.;Grübler, Y. (...)Stalla, G.K. Molecular and Cellular Endocrinology. 167(1-2):99-106